Journal
JOURNAL OF EXPERIMENTAL MEDICINE
Volume 191, Issue 7, Pages 1209-1219Publisher
ROCKEFELLER UNIV PRESS
DOI: 10.1084/jem.191.7.1209
Keywords
Fas ligand; apoptosis; neutrophil; chemotaxis; lymphoma
Categories
Funding
- NCI NIH HHS [T32CA64070] Funding Source: Medline
- NIGMS NIH HHS [GM58724] Funding Source: Medline
Ask authors/readers for more resources
Fas ligand (FasL) has been shown to mediate both apoptotic and inflammatory reactions. To rigorously assess the physiological role of different forms of the FasL molecule with regard to these two distinct processes, we isolated stably transfected lymphoma cell lines that expressed either murine wild-type FasL, membrane-only FasL, or functionally distinct forms of soluble FasL. First, the ability of these lines to induce an inflammatory response was assessed in vivo by injecting the transfectants intraperitoneally and measuring subsequent neutrophil extravasation into the peritoneal cavity. Second, lines were assessed by injecting the transfectants subcutaneously and monitoring their growth as solid tumors. Our study clearly demonstrated that the extent of inflammation induced by the transfectants directly correlated with their relative cytotoxic activities. A neutrophil response could only be elicited in mice with intact Fas death domains although Fas expression by the neutrophils was not essential. Lymphoma cells expressing the soluble FasL iol-nl corresponding to the natural cleavage product could not trigger apoptosis and did not induce a neutrophil response. In contrast to the other Fast transfectants. these cells survived as tumor transplants. However, expression of soluble FasL was not benign, but actually suppressed the inflammatory response and protected other transfectants from the effector mechanisms elicted by membrane-bound FasL.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available